GreenSky Accelerator Fund invests in Mirexus Biotechnologies

The GreenSky Accelerator Fund I LP, a venture capital fund formed in July, has invested in Mirexus Biotechnologies Inc, a natural biomaterials company based in Guelph, Ontario. The fund joined a $4.5 million syndicate alongside Goddard Enterprises Ltd, which invested in the company earlier this year, as well as Japan's Asahi Kasei Corp. Mirexus, a client of Canadian innovation hub RIC Centre, is commercializing a novel nanotechnology that can be used in a wide variety of markets, including cosmetics and nutraceuticals. As part of the investment, GreenSky Principal Greg Stewart has been named chairman of the company's board of directors.

8 October 2015•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail